NCT06707142View on ClinicalTrials.gov

A Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Behavior in the Body of TBD11

PHASE1RecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

December 5, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Healthy Adult Participants
Interventions
DRUG

TBD11

TBD11 will be administered orally.

DRUG

Placebo

Placebo will be administered orally.

Trial Locations (1)

68502

RECRUITING

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

Gates Medical Research Institute

OTHER